Diagnosis of Fatty Pancreas by FibroScan
NCT07255989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-12-01
Summary
Example 2: Interventional study The goal of this observational study is to learn know about the use of FibroScan in diagnosis of fatty pancreas in obese and non obese patients which done for the first time at worldwide as well as Egypt .The participtants already came to do liver FibroScan at center of excellence , Benha University , Egypt. Untill now the diagnosis of fatty pancreas by MRI which accurate and specific and diagnose fatty pancreasif it is more than 6.2% . lough the use of abdominal ultrasound also is proved . The use of digital fibroscan which is easy non invasive , unique as well as we can diagnose fibrosis too in the same sitting .So it is highly recommended to be add with examination of liver by fibroscan.
Conditions
- To Assess Feasibility of the New Application
Interventions
- DEVICE
-
meeting about the nutrition
In the meeting time abou the nutrition we talk about our ancient egyptian food which confirmed with Carton already present at center of excellence ,
Sponsors & Collaborators
-
Benha University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-19
- Primary Completion
- 2024-04-19
- Completion
- 2024-05-05
Countries
- Egypt
Study Locations
More Related Trials
-
Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study
NCT01306110 ·Status: COMPLETED
-
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
NCT02575625 ·Status: UNKNOWN ·Phase: NA
-
AI Models vs Non-Invasive Fibrosis Scores in MAFLD Diagnosis
NCT07305636 ·Status: COMPLETED
-
Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression
NCT02267148 ·Status: COMPLETED
-
Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients
NCT00926224 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery
NCT03548597 ·Status: COMPLETED
-
Fatty Liver Among Employees at Banha University
NCT04367012 ·Status: COMPLETED
-
Prevalence of NAFLD in T1DM Patients
NCT06445361 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
NCT02682394 ·Status: UNKNOWN
-
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
NCT01997424 ·Status: COMPLETED ·Phase: NA
-
Pancreas Volume and Diabetes Status Following Pancreatectomy
NCT02823678 ·Status: UNKNOWN
-
Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
NCT03961516 ·Status: COMPLETED
-
Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients
NCT05804409 ·Status: UNKNOWN
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients
NCT03872024 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Mri and Ultrasound Elastography in Pancreatic Masses
NCT06895655 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease
NCT02779946 ·Status: COMPLETED
-
Relation Between NAFLD and BM DENSITY
NCT06038253 ·Status: NOT_YET_RECRUITING
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
NCT06739330 ·Status: RECRUITING
-
Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )
NCT05790057 ·Status: UNKNOWN
-
MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
NCT06492369 ·Status: COMPLETED
-
Fatty Liver and Pancreatic Steatosis
NCT06757348 ·Status: NOT_YET_RECRUITING
-
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
NCT06160271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2